Electrical probing of COVID-19 spike protein receptor binding domain via
  a graphene field-effect transistor by Zhang, Xiaoyan et al.
 1 
 
Electrical probing of COVID-19 spike protein receptor binding 
domain via a graphene field-effect transistor 
 
Xiaoyan Zhanga,d, Qige Qia, Qiushi Jinga, Shen Aoa,b, Zhihong Zhangc, Mingchao Dingc, 
Muhong Wuc, Kaihui Liuc, Weipeng Wangb, Yunhan Lingb, Zhengjun Zhangb, 
Wangyang Fua,b,* 
 
a State Key Laboratory of New Ceramics and Fine Processing, School of Materials 
Science and Engineering, Tsinghua University, Shaw technical science building, 
Haidian District, Beijing, 100084, P. R. China 
b Key Laboratory of Advanced Materials of Ministry of Education, School of Materials 
Science and Engineering, Tsinghua University, Shaw technical science building, 
Haidian District, Beijing, 100084, P. R. China 
c State Key Laboratory for Mesoscopic Physics, Frontiers Science Center for Nano-
optoelectronics, School of Physics, Peking University, Beijing 100871, China 
d Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333CC Leiden, 
the Netherlands 
 
 
 
 
*Correspondence author: fwy2018@mail.tsinghua.edu.cn  
 2 
 
Abstract 
Here, in an effort towards facile and fast screening/diagnosis of novel coronavirus 
disease 2019 (COVID-19), we combined the unprecedently sensitive graphene field-
effect transistor (Gr-FET) with highly selective antibody-antigen interaction to develop 
a coronavirus immunosensor. The Gr-FET immunosensors can rapidly identify (about 
2 mins) and accurately capture the COVID-19 spike protein S1 (which contains a 
receptor binding domain, RBD) at a limit of detection down to 0.2 pM, in a real-time 
and label-free manner. Further results ensure that the Gr-FET immunosensors can be 
promisingly applied to screen for high-affinity antibodies (with binding constant up to 
2×1011 M-1 against the RBD) at concentrations down to 0.1 pM. Thus, our developed 
electrical Gr-FET immunosensors provide an appealing alternative to address the early 
screening/diagnosis as well as the analysis and rational design of neutralizing-antibody 
locking methods of this ongoing public health crisis. 
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Rapid and accurate identification/characterization of a potential pathogen is crucial for 
disease control, patient treatment and prevention of epidemic of emerging infectious 
diseases, such as the severe acute respiratory syndrome coronavirus (SARS-COV), 
which has incurred pandemics of respiratory infectious diseases with high mortality. 
Recently, another emerging coronavirus that can cause viral pneumonia (COVID-19) 
is outbreak in Wuhan, China and has propagated across the entire China. Meanwhile it 
has already shown great potential to have globe spread and thread to the worldwide 
public health.1, 2 To date, nucleic acid-based molecular diagnostic tests based on the 
reverse transcription-polymerase chain reaction (RT-PCR),3 have been established and 
widely adopted to identify this COVID-19. However, these detection methods require 
sophisticated primer and probe design, multi-step reactions, many reagents, trained 
personnel and bulky instruments. Moreover, it is impossible or inaccurate to detect 
infected but recovered people or asymptomatic carriers. In this respect, simple and cost-
efficient protein-based immunosensor with high sensitivity is of vital importance when 
pestilential blast.  
Graphene field-effect transistors (Gr-FET) are very attractive for the development 
of immunosensors due to their unprecedented sensitivity and chemical stability with 
proved capability for label-free digital biomolecules detection.4-6 Compared to optical 
based immunoassays including fluorescence-linked and/or enzyme-linked 
immunosorbent assay (FLISA and/or ELISA) technology, Gr-FET biosensors eliminate 
the complicated procedure for fluorescence or enzyme labeling and do not require bulky 
and expensive optical instruments. Thus, facile Gr-FET biosensors with high sensitivity 
hold great potential for rapid diagnosis and early risk prediction of infectious diseases, 
which often present low copy numbers in vivo pathogen. In the case of coronaviruses, 
it has been reported that its spike (S) glycoprotein plays an extremely important role in 
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recognizing the cell surface receptor, which is essential for both host specificity and 
viral infectivity. Further studies confirms that COVID-19 infects the human respiratory 
epithelial cells through the S1 subunit protein, which mainly contains a receptor binding 
domain (RBD) interacting with the human angiotensin-converting enzyme 2 (ACE2).7 
Moreover, the S protein also plays key parts in the induction of neutralizing-antibody 
and T-cell responses, as well as protective immunity.8 
Here, to enable digital detection of the virion attachment protein of coronaviruses 
for fast screening/diagnosis, we combined the extremely sensitive Gr-FET with highly 
selective SARS-COV spike S1 subunit protein antibody (CSAb) - COVID-19 spike S1 
subunit protein (which contains the RBD) antigen interaction to develop an 
immunosensor. Strikingly, CSAb modified Gr-FET is capable of real-time detecting S1 
at a limit of detection (LOM) down to 0.2 pM concentration with a fast responding time 
within 2 mins. Moreover, our results indicate that CSAb modified Gr-FET possesses a 
higher sensitivity than its counterpart with ACE2 receptors, which can be attributed to 
the higher bonding affinity of CSAb to S1 (K=2×1011 M-1) compared to that of ACE2 
(K=109 M-1). Thus, along with the capability of utilizing S1 modified Gr-FET to 
screening antibodies, we expand the potential utility of Gr-FET for rapid 
screening/diagnosis of respiratory infections caused by coronaviruses and its fast drug 
screening. 
We started with high-quality monolayer single crystal graphene synthesized on 
single crystal Cu(111) foils by a chemical vapor deposition (CVD) method (Fig. S1),9 
and fabricated high-performance, solution-compatible Gr-FETs following an “upside-
down” process described previously.10 Figure 1a depicts the schematics of Gr-FET for 
coronaviruses diagnosis, where graphene surface was specifically functionalized with 
either CSAb or ACE2 receptor to bind the S1 subunit protein from COVID-19. The 
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hybridization of the slightly positively charged S1 protein with CSAb/ACE2 receptors 
immobilized on the graphene surface, alters its conductance/resistance via field effect, 
which can be electrically read out. We note here that we applied a reference electrode 
in constant contact with the antigen buffer solution to fix its electrostatic potential (Vref) 
during antibody-antigen reaction, and to control the current flow in the graphene 
channel between the source and the drain electrodes. As CSAb is positively charged, 
while ACE2 is negatively charged in PBS buffer solution (pH=7.2), we applied a 
negative or a positive potential at graphene during the incubation process, respectively, 
to improve their immobilization on the sensor surface. 
Figure 1b plots the sheet conductance (G) of graphene measured at a constant 
current source Ids ~ 1 μA when sweeping the liquid-gate voltage Vref ranging from −0.5 
to 0.3 V. The transfer characteristics gives the liquid-gate voltage of a bare Gr-FET 
device at the charge neutrality point (CNP, also called Dirac point) VDirac=-90 mV, 
where the total charge carrier number is minimal. Initial field-effect carrier mobilities 
can be deduced as 1017 cm2 V-1 for hole and 1215 cm2 V-1 for electron. 30 min-
incubation of CSAb results in a shift of the Dirac point ΔVDirac=-50 mV towards 
negative direction (red dots, Fig. 1b), which can be attributed to the positive charges 
carried by the immobilized antibodies. To confirm the adhesion of the self-assembly 
CSAb on graphene surface, in another Gr-FET sample we treated the CSAb 
immobilized sensor surface with tween 20 (T20), a surfactant with known 
blocking/passivation effect on graphene surface. We observed negligible change in the 
transfer characteristics before and after T20 passivation for 30 mins (Fig. S2), 
suggesting its good adhesion and tight surface coverage via hydrophobic and 
electrostatic interactions during its self-assembly on graphene surface.  
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Figure 1. Protein functionalized Gr-FET immunosensors. (a) Schematics of the Gr-FET 
immunosensors. We functionalize the graphene surface with either CSAb or ACE2 receptor, which 
have proved affinity for the S1 subunit protein (which contains the RBD) from coronaviruses. (b) 
Electrical source-drain sheet conductance G as a function of the reference potential Vref measured 
for the CSAb immobilized Gr-FET. A bipolar transfer curve is observed corresponding to different 
type of charge carriers that can continuously be tuned from holes (left) to electrons (right) with a 
Dirac point VDirac at minimum G.  
 
Due to Debye screen in the 10 mM PBS buffer solution (Debye length=0.7 nm), 
the charged S1 subunit protein cannot approach the graphene surface close enough to 
induce a notable field-effect, as the expected size of the antibody is around 7-10 nm,11 
i.e., one order-of-magnitude larger than the Debye length of the buffer solution. To 
alleviate the ionic screening effect, we performed all the real-time sensing test under 
diluted 0.01 PBS with elongated Debye length of 7 nm (comparable to the size of the 
CSAb).  
During real-time antibody-antigen reaction, we fixed the liquid-gate voltage (Vref) 
at 0 V (electron branch), where the G-Vref curve exhibit a sharp slope, thus a high 
sensing response. For signal processing, we normalized the change of the conductance 
ΔG by the transconductance gm to deduce the shift of the liquid-gate voltage 
ΔVref=ΔG/gm of Gr-FET upon antibody-antigen reaction. Such normalization helps to 
eliminate the effect of sensor-to-sensor variation in electrical parameters, thus yielding 
a reliable and reproducible sensing performance. Figure 2a shows the real-time 
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responses (ΔVref) monitored at varying concentrations of S1 ranging from 0.2 pM to 10 
nM (added at time intervals of about 5 mins with increasing concentration). The 
decrease of ΔVref depending on the increasing concentration of S1 is consistent with the 
bonding of slightly positively charged molecules on the sensor surface. Such CSAb-S1 
complex can be refreshed and reused with comparable performance after thoroughly 
rinsing with buffer solution (Fig. S3). Additionally, repeating the same measurement 
when shifting the liquid-gate voltage from Vref=0 V (electron branch) to Vref=-0.2 V 
(hole branch), yields similar sensing behavior as expected (Fig. S4). As a negative 
control, pure T20 modified Gr-FET was also tested (Fig. S5). Compared to the CSAb 
immobilized Gr-FET immunosensor, T20 passivated Gr-FET shows negligible sensing 
response to the target S1. Therefore, our results clearly suggest that Gr-FET signal 
output is specific to the immobilized CSAb-S1 complex. Strikingly, such CSAb 
immobilized Gr-FET immunosensors target S1 subunit protein of COVID-19 with a 
limit of detection (LOD) down to 0.2 pM, which rivals that of state-of-the-art ELISA 
technology but eliminating the requirements of complicated procedure for enzyme 
labeling or bulky/expensive optical instruments.12, 13 We note here that there is still 
plenty of room for improving the LOD by innovative antibody design and/or optimal 
Gr-FET sensing scheme. In addition, the real-time monitoring of the ΔVref response 
(Fig. 2a) indicates a fast response time (within 2 min) for the detection of S1, which 
competes the current fast FLISA and/or ELISA technologies.13  
Alternatively, ACE2 is an integral membrane protein served as functional 
receptor for the spike glycoprotein of human coronaviruses SARS and COVID-19 
infections. We further examined the affinity of ACE2-functionalized Gr-FET in the 
presence of S1 subunit protein at varying concentrations (10 pM–1 µM). In contrast to 
CSAb, real-time measurement of ACE2-functionalized Gr-FET immunosensor (Fig. 2b) 
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suggest that sharp increase/change of ΔVDirac happened only when 1 nM S1 was added. 
Further affinity fitting based on a single-reaction model10 (see also SI) in Fig. 1e give 
binding affinities of K=2×1011 M-1 and K=109 M-1 for CSAb-S1 and ACE2-S1 
interaction, respectively. Obviously, compared to the ACE2 modified Gr-FET, its 
CSAb modified counterpart exhibits a much higher affinity to the S1 subunit protein of 
COVID-19,14, 15 which is in consistent with previous reports that the antibody can 
scavenging virus before they bonding to receptors. 
 Neutralizing antibodies are extraordinarily crucial in the development of 
vaccines and antibody drugs. Here, to screen the neutralizing antibody, we 
functionalized Gr-FET with S1 protein to differential its affinity to CSAb or ACE2 in 
real-time. The results indicate a sensing response to CSAb even at 0.1 pM 
concentration;(Fig. 2d) whereas clear and sharp response can be identified for ACE2 
only after 1 nM (Fig. 2e). In Fig. 1f, affinity fitting using our previously determined 
binding constants of K=2×1011 M-1 and K=109 M-1 gives good description for CSAb-
S1 and ACE2-S1 interactions, respectively, also confirming our previous results and 
conclusions on CSAb or ACE2 immobilized Gr-FET for S1 detection. Here we ascribe 
the slight deviations in the affinity fitting for CSAb-S1 interaction at 0.1 pM and 1 pM 
concentration (Fig. 2f) to possible ionic screening of the weakly charged CSAb with 
relatively large size. 
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Figure 2. Protein functionalized Gr-FET immunosensors for detection of COVID-19 related 
proteins. (a) Changes of the CSAb immobilized Gr-FET’s Vref versus time upon the introduction of 
S1 solutions at various concentration from 0.2 pM to 10 nM in 0.1 mM PBS buffer solution. (b) 
Changes in Vref of ACE2 immobilized Gr-FET versus time upon the introduction of S1 solutions 
with various concentration from 10 pM to 1 µM in 0.1 mM PBS buffer solution. (c) Affinity fittings 
of the CSAb and the ACE2 mobilized Gr-FETs for CSAb-S1 (red dot and red line fit) and ACE2-
S1 (blue dot and blue line fit) interactions, yield binding affinities K=2×1011 M-1 and K=109 M-1, 
respectively. (d) Detection of CSAb with S1 spike functionalized Gr-FET biosensors. Changes of 
the S1 immobilized Gr-FET’s Vref versus time upon the introduction of CSAb solutions at various 
concentrations ranging from 0.1 pM to 10 nM in 0.1 mM PBS buffer solution. (e) Detection of 
ACE2 with S1 spike functionalized Gr-FET biosensors. Changes of the CSAb immobilized Gr-
FET’s Vref versus time upon the introduction of ACE2 solutions at various concentrations ranging 
from 0.1 pM to 10 nM in 0.1 mM PBS buffer solution. (f) Affinity fittings using previously obtained 
equilibrium constants of S1 immobilized Gr-FET for CSAb-S1 (red dot and red line fit) and ACE2-
S1 (blue dot and blue line fit) interactions, respectively. 
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In summary, we expand the applications of label-free Gr-FET digital biosensing 
technology to fast detection of COVID-19 spike protein S1 (which contains the RBD) 
with sensitivities rivaling those of state-of-the-art ELISA technologies, but eliminating 
any requirements of complicated procedure for enzyme labeling or bulky/expensive 
optical instruments. We constructed the Gr-FET immunosensors by immobilizing 
either CSAb or ACE2 on the surface of the graphene, both of which bind specifically 
to the spike protein RBD. A direct comparison between CSAb and ACE2 based Gr-
FET biosensors indicates that CSAb has a higher affinity to the spike protein RBD with 
a LOM down to 0.2 pM. Moreover, we demonstrated the principle of spike protein S1 
antigen functionalized Gr-FETs for fast analysis and screening of neutralizing 
antibodies, which can block coronaviruses from attaching and infecting the health cell. 
Thus, these results have important implications in the context of rapid and facile digital 
immune-specific identification, as well as research and development of vaccines, 
prophylactics and therapeutics to combat COVID-19 and other emerging coronavirus 
associated infectious diseases, specifically during the outbreak period of pandemics.  
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Fig. S1 Raman spectroscopy of monolayer single crystal CVD graphene for fabrication 
of Gr-FET immunosensors. 
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Fig. S2 Electrical source-drain conductance G as a function of the reference voltage Vref 
measured for the CSAb-immobilized Gr-FET before and after surface passivation by 
30-min-T20 incubation at 0.05 wt% concentration. The results indicate a negligible 
change on the Gr-FET electrical performance due to T20 passivation. 
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Fig. S3 Changes of the liquid-gate voltage ΔVref upon sufficient buffer solution rinsing 
suggests that CSAb-S1 complex can be refreshed. (a) First time refreshment and (b) 
second time refreshment. ΔVref≈12.5 mV indicates the baseline level of the CSAb 
modified Gr-FET. 
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Fig. S4 (a) Change of the liquid-gate voltage ΔVref of CSAb immobilized Gr-FET 
versus time upon the introduction of S1 solutions at various concentration from 10 pM 
to 10 nM. (b) Shifting the liquid-gate voltage from Vref=0 V (a) to Vref=-0.2 V (and 
fixing at -0.2 V) yields similar sensing behavior for CSAb immobilized Gr-FET upon 
the introduction of S1 solutions at various concentrations ranging from 10 pM to 10 
nM. 
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Fig. S5 Change of the gate voltage of T20 passivated Gr-FET versus time upon the 
introduction of S1 solution at 1 nM. No clear sensing response can be observed. 
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Single-reaction model 
The 𝐶𝑆𝐴𝑏 − 𝑆1 complex system can be expressed by the dissociation constant 𝐾𝑑: 
 𝐶𝑆𝐴𝑏 − 𝑆1𝑥+
𝐾𝑑
⇔ 𝐶𝑆𝐴𝑏 + 𝑆1𝑥+, 𝐾𝑑 =
𝑣𝐶𝑆𝐴𝑏∙ 𝑎𝑠1𝑥+
𝑣𝐶𝑆𝐴𝑏−𝑆1𝑥+
=
1
𝐾
                                     (S1) 
here v is the number of sites of each species, 𝑎𝑠1𝑥+ the activity of the positively charged 
𝑆1𝑥+ at the sensor surface, 𝐾 the binding affinity. The active surface sites are either 
complex 𝐶𝑆𝐴𝑏 − 𝑆1𝑥+, or free 𝐶𝑆𝐴𝑏. The total number of these sites is: 
𝑁𝑠 = 𝑣𝐶𝑆𝐴𝑏−𝑆1𝑥+ + 𝑣𝐶𝑆𝐴𝑏                                                (S2) 
For simplifying the calculation, we assume the 𝐶𝑆𝐴𝑏 and 𝑆1 carrier zero and 
𝑥e charges, respectively. The complex 𝐶𝑆𝐴𝑏 − 𝑆1𝑥+ generates the total surface charge: 
𝜎0 = 𝑥𝑒𝑣𝐶𝑆𝐴𝑏−𝑆1𝑥+                                                           (S3) 
Eq. S1-3 can be rewritten: 
𝜎0 = 𝑥𝑒𝑁𝑠(
𝑎
𝑆1𝑥+
𝑎𝑆1𝑥++𝐾𝑑
)                                                      (S4) 
These surface charge σ0 are screened by the ions of the double layer, yielding a 
surface potential drop Ψ0 over the double-layer capacitance CDL: 
𝜎0 = 𝐶𝐷𝐿 ∙  𝛹0                                                          (S5) 
Via the Boltzmann equation, we relate the (unknown) activity of the surface 
𝑆1𝑥+ in Eq. S4 with the (known) activity of the bulk solution 𝑆1𝑏
𝑥+: 
𝑎𝑆1𝑥+ = 𝑎𝑆1𝑏
𝑥+ ∙ 𝑒𝑥𝑝(−
𝑒𝛹0
𝑘𝑇
)                                             (S6) 
 Therefore, we may derive an explicit relationship between the bulk 𝑆1𝑥+ 
activity 𝑎𝑆1𝑏
𝑥+ and the surface potential Ψ0: 
𝑎𝑆1𝑏
𝑥+ = 𝐾𝑑 ∙ 𝑒𝑥𝑝(
𝑒𝛹0
𝑘𝑇
) ∙ (
𝐶𝐷𝐿𝛹0
𝑥𝑒𝑁𝑠−𝐶𝐷𝐿𝛹0
)                                   (S7) 
 The mechanism can be modeled similarly in case of 𝐴𝐶𝐸2 − 𝑆1  complex 
system. 
